Clinical performance evaluation of a rapid, low throughput test for KRAS, BRAF and EGFR mutation analysis

被引：0
|
作者：
Muriira, A. G. [1 ]
Mukadam, R. [1 ]
机构：
[1] Pathologists Lancet Kenya, Nairobi, Kenya
来源：
CLINICA CHIMICA ACTA | 2022年 / 530卷
关键词：
D O I：
10.1016/j.cca.2022.04.868
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
W113
引用
收藏
页码：S332 / S333
页数：2
相关论文
共 50 条
  • [41] EGFR Mutation Analysis: Performance Evaluation of Blood Collection Tubes for ccfDNA Stabilization
    Ullius, A.
    Groelz, D.
    Krenz, T.
    Provencher, E.
    Voss, T.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1231 - 1231
  • [42] Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples
    Offerman, Saskia
    Prinsen, Clemens F.
    Knol, Ageeth
    Methorst, Natalie
    Kamphorst, Jeanette
    Niemantsverdriet, Maarten
    [J]. DIAGNOSTIC PATHOLOGY, 2021, 16 (01)
  • [43] Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples
    Saskia Offerman
    Clemens F. Prinsen
    Ageeth Knol
    Natalie Methorst
    Jeanette Kamphorst
    Maarten Niemantsverdriet
    [J]. Diagnostic Pathology, 16
  • [44] Mutation analysis of the Ras pathway genes NRAS, KRAS, HRAS and BRAF in human glioblastomas
    Knobbe, CB
    Reifenberger, J
    Reifenberger, G
    [J]. ACTA NEUROPATHOLOGICA, 2004, 108 (04) : 352 - 352
  • [45] Mutation Analysis of KRAS NRAS and BRAF Genes Among Indian Patients with Colorectal Cancer
    Das, B.
    Bagadi, S.
    Nair, S.
    Chheda, P.
    Rau, S.
    Pany, A.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 905 - 905
  • [46] EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
    Lu, Hong-Yang
    Qin, Jing
    Han, Na
    Lei, Lei
    Xie, Fajun
    Li, Chenghui
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 2217 - 2226
  • [47] EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
    Lu, Hongyang
    Mao, Weimin
    Cheng, Qiao-Yuan
    Xu, Hai-Miao
    Cai, Ju-Fen
    Wang, Xiaojia
    Lou, CaiJin
    Qin, Jing
    Ye, Wei-Wu
    Han, Na
    Lei, Lei
    Ling, Zhiqiang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Radiomic CT features for evaluation of EGFR and KRAS mutation status in patients with advanced NSCLC
    De Jong, E. E. C.
    Van Elmpt, W.
    Hendriks, L. E. L.
    Leijenaar, R. T. H.
    Dingemans, A. M. C.
    Lambin, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S290 - S291
  • [49] Performance Evaluation of a Commercially Available KRAS Mutation Detection Assay
    Miravalle, L.
    Cheng, L.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 651 - 651
  • [50] Evaluation of the Idylla KRAS and NRAS mutation test in colorectal cancer tissue
    Zekri, Jamal
    Baghdadi, Mohammed A.
    Alardati, Hosam
    Khallaf, Hamoud
    Kabanja, Juma H.
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2019, 110
12345